Richard T Penson

Richard T Penson

UNVERIFIED PROFILE

Are you Richard T Penson?   Register this Author

Register author
Richard T Penson

Richard T Penson

Publications by authors named "Richard T Penson"

Are you Richard T Penson?   Register this Author

100Publications

2212Reads

23Profile Views

Second-line lenvatinib in patients with recurrent endometrial cancer.

Gynecol Oncol 2020 Mar 17;156(3):575-582. Epub 2020 Jan 17.

Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.12.039DOI Listing
March 2020

Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer.

Int J Gynecol Cancer 2020 Feb 6;30(2):201-206. Epub 2020 Jan 6.

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-000851DOI Listing
February 2020

Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.

Gynecol Oncol 2020 Feb 18. Epub 2020 Feb 18.

Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Sarah Cannon Research Institute, Nashville, TN, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.01.037DOI Listing
February 2020

CD90 MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer.

Oncotarget 2019 Jul 8;10(43):4479-4491. Epub 2019 Jul 8.

Vaccine and Immunotherapy Center, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/27065
Publisher Site
http://dx.doi.org/10.18632/oncotarget.27065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633895PMC
July 2019

Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.

J Allergy Clin Immunol Pract 2017 Jan - Feb;5(1):177-178. Epub 2016 Sep 15.

Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2016.07.010DOI Listing
December 2018

Frontline therapy of ovarian cancer: trials and tribulations.

Curr Opin Obstet Gynecol 2018 Feb;30(1):1-6

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GCO.0000000000000434DOI Listing
February 2018

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.

Br J Cancer 2018 01 28;118(2):162-170. Epub 2017 Nov 28.

Department of Pathology (SL) and Department of Gynecologic Oncology (KT), Irvine Medical Center, University of California, Orange, CA 92868, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785748PMC
January 2018

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.

N Engl J Med 2016 Feb;374(8):738-48

From the California Pacific-Palo Alto Medical Foundation, Sutter Cancer Research Institute, San Francisco (J.K.C.); NRG Oncology-Gynecologic Oncology Group Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY (M.F.B., H.H.); Massachusetts General Hospital, Boston (R.T.P., M.J.B.); University of Oklahoma, Oklahoma City (J.L.W.); Women and Infants Hospital, Providence, RI (P.A.D.S.); University of Pennsylvania (S.C.R.) and Fox Chase Cancer Center (L.P.M.) - both in Philadelphia; University of Colorado Cancer Center, Aurora (S.A.D.); University of Alabama at Birmingham, Birmingham (W.K.H.); James Cancer Center, Ohio State University, Columbus (D.M.O.); Minnesota Oncology/Hematology-Oncology Service, Edina (M.P.B.); Indiana University School of Medicine, Carmel (H.M.); and University of Arizona Cancer Center, Creighton University School of Medicine, and St. Joseph's Hospital and Medical Center (B.J.M.) - all in Phoenix.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081077PMC
http://dx.doi.org/10.1056/NEJMoa1505067DOI Listing
February 2016

Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.

Semin Radiat Oncol 2016 Jan 4;26(1):3-8. Epub 2015 Sep 4.

Gynecologic Oncology Program, Massachusetts General Hospital Cancer Center, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2015.09.004DOI Listing
January 2016

Theorist's Toy: Equipoise.

J Natl Compr Canc Netw 2015 Jul;13(7):936-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0108DOI Listing
July 2015

Primary debulking surgery for advanced ovarian cancer: are you a believer or a dissenter?

Gynecol Oncol 2014 Dec 12;135(3):595-605. Epub 2014 Oct 12.

Division of Medical Gynecologic Oncology, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.10.007DOI Listing
December 2014

Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer.

Expert Rev Clin Pharmacol 2014 Jul 18;7(4):443-50. Epub 2014 Apr 18.

Division of Hematology Oncology, Yawkey 9-064, Massachusetts General Hospital, 32 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2014.909723DOI Listing
July 2014

Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.

J Natl Cancer Inst 2014 Jul 8;106(7). Epub 2014 Jul 8.

Affiliations of authors: Supportive Care Medicine Department, Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL (KAD); Acute and Tertiary Care Department, University of Pittsburgh School of Nursing, Pittsburgh, PA (HSD); Department of Medical Social Sciences and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL (DC); Center for Patient Partnership, University of Wisconsin Law School, Madison, WI (MEG); Department of Medicine, Massachusetts General Hospital, Boston, MA (RTP); Department of Reproductive Medicine, Division of Gynecologic Oncology, University of California-San Diego, San Diego, CA (SCP); Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Summa Akron City Hospital, Akron, OH (VEvG); School of Nursing, Emory University, Atlanta, GA (DWB); Department of Health Policy and Management, University of North Carolina, Chapel Hill, NC (BBR); Department of Medicine, University of California, Irvine, Irvine, CA (LW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110471PMC
July 2014

Caring for one of our own.

Oncologist 2014 May 10;19(5):545-9. Epub 2014 Apr 10.

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012977PMC
May 2014

Improved survival with bevacizumab in advanced cervical cancer.

N Engl J Med 2014 Feb;370(8):734-43

From the University of California, Irvine, Medical Center, Orange (K.S.T.); Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo (M.W.S., H.H.); Mayo Clinic, Rochester, MN (H.J.L.); Massachusetts General Hospital, Boston (R.T.P.); M.D. Anderson Cancer Center, Houston (L.M.R.); University of Oklahoma, Oklahoma City (L.M.L.); Vall d'Hebron University Hospital, Barcelona (A.O.); University of Cincinnati College of Medicine-Women's Cancer Center at Kettering, Kettering, OH (T.J.R.); Memorial Sloan-Kettering Cancer Center, New York (M.M.L.); Indiana University School of Medicine, Indianapolis (H.E.M.); and the University of Arizona Cancer Center and Creighton University at St. Joseph's Hospital and Medical Center, Phoenix (B.J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1309748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010094PMC
February 2014

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

J Clin Oncol 2013 Dec 14;31(35):4400-6. Epub 2013 Oct 14.

R. Wendel Naumann and James T. Symanowski, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, University of Texas, Houston; Michael G. Teneriello, Texas Oncology, Austin, TX; Robert A. Burger, Fox Chase Cancer Center, Philadelphia, PA; Edward A. Sausville, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Elzbieta Kutarska, Centrum Onkologii Ziemi Lubelskiej, Lubland; Elzbieta Nowara, Instytut im. Marii Skłodowskiej-Curie, Gliwice, Poland; Sharad A. Ghamande, Georgia Health Sciences University, Augusta, GA; Nashat Y. Gabrail, Gabrail Cancer Center, Canton, OH; Stephen E. DePasquale, Chattanooga's Program in Women's Oncology, Chattanooga, TN; Lucy Gilbert, McGill University Health Centre, Montreal, Quebec, Canada; Robert H. Gersh, Cancer Care Northwest, Spokane, WA; Wael A. Harb, Horizon Oncology Research, Lafayette; Chandra D. Lovejoy, Christopher P. Leamon, David E. Morgenstern, and Richard A. Messmann, Endocyte, West Lafayette, IN; Panagiotis A. Konstantinopoulos, Beth Israel Deaconess Medical Center; and Richard T. Penson, Dana-Farber Cancer Center, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/10/14/JCO.2013.49
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.49.7685
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.49.7685DOI Listing
December 2013

Ascites analysis by a microfluidic chip allows tumor-cell profiling.

Proc Natl Acad Sci U S A 2013 Dec 2;110(51):E4978-86. Epub 2013 Dec 2.

Center for Systems Biology, Massachusetts General Hospital, Boston, MA 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1315370110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870756PMC
December 2013

Ovarian cancer, version 2.2013.

J Natl Compr Canc Netw 2013 Oct;11(10):1199-209

From 1City of Hope Comprehensive Cancer Center; 2University of Alabama at Birmingham Comprehensive Cancer Center; 3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 4Fox Chase Cancer Center; 5UCSF Helen Diller Family Comprehensive Cancer Center; 6he Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Vanderbilt-Ingram Cancer Center; 8The University of Texas MD Anderson Cancer Center; 9University of Washington/Seattle Cancer Care Alliance; 10Moffitt Cancer Center; 11Duke Cancer Institute; 12University of Michigan Comprehensive Cancer Center; 13Roswell Park Cancer Institute; 14Dana-Farber/Brigham and Women's Cancer Center; 15Massachusetts General Hospital Cancer Center; 16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 17Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 18Memorial Sloan-Kettering Cancer Center; 19St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 21Stanford Cancer Institute; 22Huntsman Cancer Institute at the University of Utah; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0142DOI Listing
October 2013

Clear cell cancer of the ovary.

Curr Opin Oncol 2013 Sep;25(5):553-7

Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328363e0c7DOI Listing
September 2013

Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding.

N Engl J Med 2013 May;368(19):1827-35

Division of Hematology and Oncology, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc1209276DOI Listing
May 2013

Complexions of compliance.

Authors:
Richard T Penson

Menopause 2013 Jan;20(1):3-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/gme.0b013e31827e8295DOI Listing
January 2013

Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.

Int J Gynecol Cancer 2012 Jul;22(6):979-86

Program in Women's Oncology, Women & Infants' Hospital/Alpert Medical School of Brown University, Providence, RI 02905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31825736fdDOI Listing
July 2012

Emerging therapeutic options for platinum-sensitive ovarian cancer patients.

Clin Adv Hematol Oncol 2011 Apr;9(4 Suppl 5):1-16

Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
April 2011

Connection: Schwartz Center Rounds at Massachusetts General Hospital Cancer Center.

Oncologist 2010 28;15(7):760-4. Epub 2010 Jun 28.

M.R.C.P., Hematology-Oncology, Yawkey 9064, 55 Fruit Street, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228008PMC
December 2010

Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patients.

Integr Cancer Ther 2010 Jun;9(2):158-67

Leonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1534735409360666DOI Listing
June 2010

Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.

Gynecol Oncol 2010 Feb 18;116(2):168-72. Epub 2009 Nov 18.

Dana-Farber/Harvard Cancer Center, representing members of the DF/HCC Gynecologic Oncology Research Group at Massachusetts General Hospital, and Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.10.075DOI Listing
February 2010

Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.

J Allergy Clin Immunol 2009 Jun;123(6):1262-7.e1

Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2009.02.042DOI Listing
June 2009

Ovarian stromal and germ cell tumors.

Semin Oncol 2009 Apr;36(2):126-36

Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2008.12.004DOI Listing
April 2009

Sugar fuels cancer.

Authors:
Richard T Penson

Cancer 2009 Mar;115(5):918-21

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24125DOI Listing
March 2009

Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.

Gynecol Oncol 2009 Feb 5;112(2):394-9. Epub 2008 Dec 5.

Department of Medical Oncology Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580800884
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2008.10.015DOI Listing
February 2009

Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.

J Clin Oncol 2008 Dec 10;26(35):5761-6. Epub 2008 Nov 10.

Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts General Hospital, Boston MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.0282DOI Listing
December 2008

Epithelioid angiosarcoma of the uterus: a review of management.

Arch Gynecol Obstet 2008 Nov 19;278(5):401-4. Epub 2008 Jul 19.

Gynecologic Oncology Division, Department of Obstetrics, Gynecology and Reproductive Biology, Massachusetts General Hospital/Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-008-0727-zDOI Listing
November 2008

Cycles within cycles.

Authors:
Richard T Penson

Menopause 2008 May-Jun;15(3):412-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/gme.0b013e31816f70bdDOI Listing
October 2008

Psychosocial issues in adolescents with cancer.

Cancer Treat Rev 2007 Nov 16;33(7):622-30. Epub 2007 Apr 16.

Department of Child Psychiatry and Pediatric Hematology-Oncology, Massachusetts General Hospital, Boston, MA 02114, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2006.12.006DOI Listing
November 2007

Hope.

Oncologist 2007 Sep;12(9):1105-13

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Yawkey 9066, 55 Fruit Street, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.12-9-1105DOI Listing
September 2007

Morphine analgesia in cancer pain: role of the glucuronides.

J Opioid Manag 2005 May-Jun;1(2):83-90

Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5055/jom.2005.0021DOI Listing
March 2007

Quality of Life Considerations in Gynecologic Cancer.

Int J Gynaecol Obstet 2006 Nov;95 Suppl 1:S247-S257

Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0020-7292(06)60040-4DOI Listing
November 2006

Teams: communication in multidisciplinary care.

Oncologist 2006 May;11(5):520-6

The Kenneth B. Schwartz Center at Massachusetts General Hospital, Department of Medicine, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-5-520DOI Listing
May 2006

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer.

Gynecol Oncol 2006 Apr 2;101(1):55-61. Epub 2005 Nov 2.

Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care Program, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.09.036DOI Listing
April 2006

Direct-to-consumer advertising in oncology.

Oncologist 2006 Feb;11(2):217-26

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-2-217DOI Listing
February 2006

Learning to cope: how far is too close?

Oncologist 2005 Jun-Jul;10(6):449-56

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-6-449DOI Listing
December 2005

Topotecan: weighing in when there are many options.

Oncologist 2005 Oct;10(9):698-700

Department of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-9-698DOI Listing
October 2005

Laughter: the best medicine?

Oncologist 2005 Sep;10(8):651-60

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-8-651DOI Listing
September 2005

Cancer as metaphor.

Oncologist 2004 ;9(6):708-16

Department of Medicine, Hematology-Oncology, Cox 548, 100 Blossom Street, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.9-6-708DOI Listing
March 2005

Fear of death.

Oncologist 2005 Feb;10(2):160-9

Department of Medicine, Division of Hematology-Oncology, Palliative Care Service, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-2-160DOI Listing
February 2005

Cone damage in patients receiving high-dose irofulven treatment.

Arch Ophthalmol 2005 Jan;123(1):29-34

Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44124, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archopht.123.1.29DOI Listing
January 2005

Silence as the speech of care.

J Support Oncol 2004 Sep-Oct;2(5):455-6

Division of Hematology at Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source
December 2004

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.

Gynecol Oncol 2004 Dec;95(3):624-31

Dana-Farber/Harvard Cancer Center Program in Gynecologic Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2004.08.028DOI Listing
December 2004

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2004. A 52-year-old woman with postmenopausal bleeding and a cystic ovarian mass.

N Engl J Med 2004 Dec;351(24):2531-8

Cancer Center, Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc049022DOI Listing
December 2004

Too old to care?

Oncologist 2004 ;9(3):343-52

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.9-3-343DOI Listing
September 2004

Help me help you: support groups in cancer therapy.

Oncologist 2004 ;9(2):217-25

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.9-2-217DOI Listing
July 2004

Breaking bad news: a patient's perspective.

Oncologist 2003 ;8(6):587-96

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.8-6-587DOI Listing
March 2004

The Kenneth B. Schwartz Center at Massachusetts General Hospital hematology-oncology department: hope for the homeless.

Oncologist 2003 ;8(5):488-95

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.8-5-488DOI Listing
February 2004

Trust violated: analgesics for addicts.

Oncologist 2003 ;8(2):199-209

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.8-2-199DOI Listing
September 2003

Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.

Clin Cancer Res 2003 Jul;9(7):2778-85

Department of Hematology/Oncology Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
July 2003

Living as a cancer surpriser: a doctor tells his story.

Oncologist 2003 ;8(1):108-22

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.8-1-108DOI Listing
May 2003

beta tubulin mutations are rare in human ovarian carcinoma.

Anticancer Res 2003 Jan-Feb;23(1B):681-6

Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
April 2003

Virtual connections: Internet health care.

Oncologist 2002 ;7(6):555-68

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Cox 548, 100 Blossom Street, Boston, MA 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.7-6-555DOI Listing
February 2003

Faith, identity, and leukemia: when blood products are not an option.

Oncologist 2002 ;7(4):371-80

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.7-4-371DOI Listing
October 2002

When does the responsibility of our care end: bereavement.

Oncologist 2002 ;7(3):251-8

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
July 2002

Between parent and child: negotiating cancer treatment in adolescents.

Oncologist 2002 ;7(2):154-62

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.7-2-154DOI Listing
June 2002

The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.

Br J Clin Pharmacol 2002 Apr;53(4):347-54

Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874271PMC
http://dx.doi.org/10.1046/j.1365-2125.2002.01554.xDOI Listing
April 2002